AYBARION TRADEEU trade movers · 2025-12 · chapter 30
EU trade movers: December 2025, Pharmaceutical products
The largest month on month and year on year changes in the trade of each EU member state with each partner country, per HS4 product in chapter 30. Flows of at least EUR 5 million in December 2025; percent lists need at least EUR 1 million in the comparison month. Every figure carries its Eurostat record ID.
November 2025 · January 2026 · All chapters, December 2025 · Atom feed
Largest month on month changes, EUR
| # | Flow | Product | December 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland imports from Germany | 3004 Medicaments | EUR 44.5 million | EUR 695.4 million 2025-11 | −EUR 650.9 million | −93.6% | DS-045409:IE:DE:3004:1:2025-12 DS-045409:IE:DE:3004:1:2025-11 |
| 2 | Ireland exports to United States | 3004 Medicaments | EUR 668.9 million | EUR 1.1 billion 2025-11 | −EUR 445.5 million | −40.0% | DS-045409:IE:US:3004:2:2025-12 DS-045409:IE:US:3004:2:2025-11 |
| 3 | Netherlands exports to Germany | 3002 Human blood | EUR 219.1 million | EUR 625.9 million 2025-11 | −EUR 406.8 million | −65.0% | DS-045409:NL:DE:3002:2:2025-12 DS-045409:NL:DE:3002:2:2025-11 |
| 4 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 2.1 billion | EUR 1.7 billion 2025-11 | +EUR 350.9 million | +20.2% | DS-045409:SI:CH:3004:2:2025-12 DS-045409:SI:CH:3004:2:2025-11 |
| 5 | Italy exports to United States | 3004 Medicaments | EUR 525.6 million | EUR 872.3 million 2025-11 | −EUR 346.6 million | −39.7% | DS-045409:IT:US:3004:2:2025-12 DS-045409:IT:US:3004:2:2025-11 |
| 6 | Germany exports to United States | 3002 Human blood | EUR 1.1 billion | EUR 1.5 billion 2025-11 | −EUR 337.3 million | −22.9% | DS-045409:DE:US:3002:2:2025-12 DS-045409:DE:US:3002:2:2025-11 |
| 7 | Belgium exports to United States | 3004 Medicaments | EUR 330.4 million | EUR 649.8 million 2025-11 | −EUR 319.4 million | −49.2% | DS-045409:BE:US:3004:2:2025-12 DS-045409:BE:US:3004:2:2025-11 |
| 8 | Italy exports to Belgium | 3004 Medicaments | EUR 301.6 million | EUR 606.9 million 2025-11 | −EUR 305.3 million | −50.3% | DS-045409:IT:BE:3004:2:2025-12 DS-045409:IT:BE:3004:2:2025-11 |
| 9 | Belgium imports from Italy | 3004 Medicaments | EUR 339.5 million | EUR 600.4 million 2025-11 | −EUR 260.9 million | −43.4% | DS-045409:BE:IT:3004:1:2025-12 DS-045409:BE:IT:3004:1:2025-11 |
| 10 | Belgium imports from Germany | 3004 Medicaments | EUR 294.8 million | EUR 526.9 million 2025-11 | −EUR 232.1 million | −44.0% | DS-045409:BE:DE:3004:1:2025-12 DS-045409:BE:DE:3004:1:2025-11 |
| 11 | Belgium exports to Italy | 3004 Medicaments | EUR 556.5 million | EUR 333.7 million 2025-11 | +EUR 222.8 million | +66.8% | DS-045409:BE:IT:3004:2:2025-12 DS-045409:BE:IT:3004:2:2025-11 |
| 12 | Germany imports from Switzerland | 3002 Human blood | EUR 346.2 million | EUR 563.4 million 2025-11 | −EUR 217.2 million | −38.5% | DS-045409:DE:CH:3002:1:2025-12 DS-045409:DE:CH:3002:1:2025-11 |
| 13 | Ireland imports from United States | 3002 Human blood | EUR 228.4 million | EUR 434.9 million 2025-11 | −EUR 206.5 million | −47.5% | DS-045409:IE:US:3002:1:2025-12 DS-045409:IE:US:3002:1:2025-11 |
| 14 | Germany exports to Belgium | 3004 Medicaments | EUR 302.9 million | EUR 508.4 million 2025-11 | −EUR 205.5 million | −40.4% | DS-045409:DE:BE:3004:2:2025-12 DS-045409:DE:BE:3004:2:2025-11 |
| 15 | Belgium imports from Ireland | 3003 Medicaments | EUR 1.4 billion | EUR 1.6 billion 2025-11 | −EUR 190.6 million | −12.3% | DS-045409:BE:IE:3003:1:2025-12 DS-045409:BE:IE:3003:1:2025-11 |
Largest month on month changes, percent
| # | Flow | Product | December 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Netherlands exports to Belgium | 3001 Glands and other organs | EUR 33.8 million | EUR 1.8 million 2025-11 | +EUR 32.0 million | +1,797.5% | DS-045409:NL:BE:3001:2:2025-12 DS-045409:NL:BE:3001:2:2025-11 |
| 2 | Netherlands imports from Italy | 3003 Medicaments | EUR 21.8 million | EUR 1.7 million 2025-11 | +EUR 20.1 million | +1,193.7% | DS-045409:NL:IT:3003:1:2025-12 DS-045409:NL:IT:3003:1:2025-11 |
| 3 | France imports from China | 3004 Medicaments | EUR 69.8 million | EUR 5.8 million 2025-11 | +EUR 63.9 million | +1,094.9% | DS-045409:FR:CN:3004:1:2025-12 DS-045409:FR:CN:3004:1:2025-11 |
| 4 | Italy exports to Taiwan | 3002 Human blood | EUR 10.4 million | EUR 1.0 million 2025-11 | +EUR 9.3 million | +933.9% | DS-045409:IT:TW:3002:2:2025-12 DS-045409:IT:TW:3002:2:2025-11 |
| 5 | Germany imports from Finland | 3004 Medicaments | EUR 17.0 million | EUR 1.7 million 2025-11 | +EUR 15.3 million | +909.0% | DS-045409:DE:FI:3004:1:2025-12 DS-045409:DE:FI:3004:1:2025-11 |
| 6 | Hungary exports to Spain | 3002 Human blood | EUR 33.9 million | EUR 3.4 million 2025-11 | +EUR 30.6 million | +904.7% | DS-045409:HU:ES:3002:2:2025-12 DS-045409:HU:ES:3002:2:2025-11 |
| 7 | Ireland imports from Italy | 3002 Human blood | EUR 37.2 million | EUR 4.1 million 2025-11 | +EUR 33.1 million | +802.1% | DS-045409:IE:IT:3002:1:2025-12 DS-045409:IE:IT:3002:1:2025-11 |
| 8 | Netherlands exports to Mexico | 3002 Human blood | EUR 16.3 million | EUR 1.8 million 2025-11 | +EUR 14.4 million | +793.3% | DS-045409:NL:MX:3002:2:2025-12 DS-045409:NL:MX:3002:2:2025-11 |
| 9 | Belgium imports from China | 3002 Human blood | EUR 8.9 million | EUR 1.1 million 2025-11 | +EUR 7.8 million | +738.2% | DS-045409:BE:CN:3002:1:2025-12 DS-045409:BE:CN:3002:1:2025-11 |
| 10 | Denmark imports from Sweden | 3002 Human blood | EUR 11.5 million | EUR 1.5 million 2025-11 | +EUR 10.0 million | +656.9% | DS-045409:DK:SE:3002:1:2025-12 DS-045409:DK:SE:3002:1:2025-11 |
| 11 | Netherlands exports to Ireland | 3001 Glands and other organs | EUR 34.4 million | EUR 4.6 million 2025-11 | +EUR 29.8 million | +654.6% | DS-045409:NL:IE:3001:2:2025-12 DS-045409:NL:IE:3001:2:2025-11 |
| 12 | Netherlands exports to Panama | 3002 Human blood | EUR 12.3 million | EUR 1.7 million 2025-11 | +EUR 10.6 million | +613.9% | DS-045409:NL:PA:3002:2:2025-12 DS-045409:NL:PA:3002:2:2025-11 |
| 13 | France exports to Iraq | 3004 Medicaments | EUR 11.7 million | EUR 1.7 million 2025-11 | +EUR 10.0 million | +574.4% | DS-045409:FR:IQ:3004:2:2025-12 DS-045409:FR:IQ:3004:2:2025-11 |
| 14 | Ireland exports to Brazil | 3002 Human blood | EUR 34.1 million | EUR 5.1 million 2025-11 | +EUR 29.1 million | +572.1% | DS-045409:IE:BR:3002:2:2025-12 DS-045409:IE:BR:3002:2:2025-11 |
| 15 | Sweden exports to Canada | 3004 Medicaments | EUR 31.2 million | EUR 4.8 million 2025-11 | +EUR 26.4 million | +552.5% | DS-045409:SE:CA:3004:2:2025-12 DS-045409:SE:CA:3004:2:2025-11 |
Largest year on year changes, EUR
| # | Flow | Product | December 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Belgium imports from Ireland | 3003 Medicaments | EUR 1.4 billion | EUR 13.0 million 2024-12 | +EUR 1.4 billion | +10,372.0% | DS-045409:BE:IE:3003:1:2025-12 DS-045409:BE:IE:3003:1:2024-12 |
| 2 | Ireland exports to Belgium | 3003 Medicaments | EUR 1.2 billion | EUR 24.6 million 2024-12 | +EUR 1.2 billion | +4,743.8% | DS-045409:IE:BE:3003:2:2025-12 DS-045409:IE:BE:3003:2:2024-12 |
| 3 | Ireland exports to United States | 3004 Medicaments | EUR 668.9 million | EUR 1.3 billion 2024-12 | −EUR 676.1 million | −50.3% | DS-045409:IE:US:3004:2:2025-12 DS-045409:IE:US:3004:2:2024-12 |
| 4 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 2.1 billion | EUR 1.5 billion 2024-12 | +EUR 611.2 million | +41.4% | DS-045409:SI:CH:3004:2:2025-12 DS-045409:SI:CH:3004:2:2024-12 |
| 5 | Belgium imports from United States | 3004 Medicaments | EUR 719.2 million | EUR 238.1 million 2024-12 | +EUR 481.1 million | +202.0% | DS-045409:BE:US:3004:1:2025-12 DS-045409:BE:US:3004:1:2024-12 |
| 6 | Netherlands imports from United States | 3002 Human blood | EUR 601.7 million | EUR 281.4 million 2024-12 | +EUR 320.3 million | +113.8% | DS-045409:NL:US:3002:1:2025-12 DS-045409:NL:US:3002:1:2024-12 |
| 7 | Belgium imports from Ireland | 3004 Medicaments | EUR 62.9 million | EUR 381.7 million 2024-12 | −EUR 318.9 million | −83.5% | DS-045409:BE:IE:3004:1:2025-12 DS-045409:BE:IE:3004:1:2024-12 |
| 8 | Germany exports to Switzerland | 3004 Medicaments | EUR 629.9 million | EUR 333.2 million 2024-12 | +EUR 296.7 million | +89.0% | DS-045409:DE:CH:3004:2:2025-12 DS-045409:DE:CH:3004:2:2024-12 |
| 9 | Italy exports to United Kingdom | 3004 Medicaments | EUR 20.5 million | EUR 310.9 million 2024-12 | −EUR 290.4 million | −93.4% | DS-045409:IT:GB:3004:2:2025-12 DS-045409:IT:GB:3004:2:2024-12 |
| 10 | Slovenia imports from Switzerland | 3004 Medicaments | EUR 561.3 million | EUR 273.9 million 2024-12 | +EUR 287.4 million | +104.9% | DS-045409:SI:CH:3004:1:2025-12 DS-045409:SI:CH:3004:1:2024-12 |
| 11 | Belgium exports to Italy | 3004 Medicaments | EUR 556.5 million | EUR 271.5 million 2024-12 | +EUR 285.1 million | +105.0% | DS-045409:BE:IT:3004:2:2025-12 DS-045409:BE:IT:3004:2:2024-12 |
| 12 | Italy imports from China | 3004 Medicaments | EUR 290.8 million | EUR 9.8 million 2024-12 | +EUR 281.0 million | +2,881.4% | DS-045409:IT:CN:3004:1:2025-12 DS-045409:IT:CN:3004:1:2024-12 |
| 13 | Netherlands imports from Ireland | 3002 Human blood | EUR 989.6 million | EUR 728.2 million 2024-12 | +EUR 261.4 million | +35.9% | DS-045409:NL:IE:3002:1:2025-12 DS-045409:NL:IE:3002:1:2024-12 |
| 14 | Spain imports from United States | 3004 Medicaments | EUR 97.6 million | EUR 339.5 million 2024-12 | −EUR 241.9 million | −71.3% | DS-045409:ES:US:3004:1:2025-12 DS-045409:ES:US:3004:1:2024-12 |
| 15 | Austria exports to United States | 3002 Human blood | EUR 124.4 million | EUR 365.1 million 2024-12 | −EUR 240.6 million | −65.9% | DS-045409:AT:US:3002:2:2025-12 DS-045409:AT:US:3002:2:2024-12 |
Largest year on year changes, percent
| # | Flow | Product | December 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Belgium imports from Ireland | 3003 Medicaments | EUR 1.4 billion | EUR 13.0 million 2024-12 | +EUR 1.4 billion | +10,372.0% | DS-045409:BE:IE:3003:1:2025-12 DS-045409:BE:IE:3003:1:2024-12 |
| 2 | Ireland imports from Italy | 3004 Medicaments | EUR 240.8 million | EUR 4.2 million 2024-12 | +EUR 236.6 million | +5,682.5% | DS-045409:IE:IT:3004:1:2025-12 DS-045409:IE:IT:3004:1:2024-12 |
| 3 | Ireland exports to Belgium | 3003 Medicaments | EUR 1.2 billion | EUR 24.6 million 2024-12 | +EUR 1.2 billion | +4,743.8% | DS-045409:IE:BE:3003:2:2025-12 DS-045409:IE:BE:3003:2:2024-12 |
| 4 | Italy imports from China | 3004 Medicaments | EUR 290.8 million | EUR 9.8 million 2024-12 | +EUR 281.0 million | +2,881.4% | DS-045409:IT:CN:3004:1:2025-12 DS-045409:IT:CN:3004:1:2024-12 |
| 5 | France imports from China | 3004 Medicaments | EUR 69.8 million | EUR 2.4 million 2024-12 | +EUR 67.4 million | +2,859.0% | DS-045409:FR:CN:3004:1:2025-12 DS-045409:FR:CN:3004:1:2024-12 |
| 6 | Netherlands imports from Denmark | 3002 Human blood | EUR 150.9 million | EUR 7.5 million 2024-12 | +EUR 143.3 million | +1,900.5% | DS-045409:NL:DK:3002:1:2025-12 DS-045409:NL:DK:3002:1:2024-12 |
| 7 | Denmark exports to Netherlands | 3002 Human blood | EUR 189.7 million | EUR 11.8 million 2024-12 | +EUR 177.9 million | +1,503.1% | DS-045409:DK:NL:3002:2:2025-12 DS-045409:DK:NL:3002:2:2024-12 |
| 8 | Finland exports to United States | 3002 Human blood | EUR 18.4 million | EUR 1.2 million 2024-12 | +EUR 17.2 million | +1,450.0% | DS-045409:FI:US:3002:2:2025-12 DS-045409:FI:US:3002:2:2024-12 |
| 9 | Italy exports to India | 3004 Medicaments | EUR 48.5 million | EUR 3.3 million 2024-12 | +EUR 45.3 million | +1,388.9% | DS-045409:IT:IN:3004:2:2025-12 DS-045409:IT:IN:3004:2:2024-12 |
| 10 | Netherlands exports to Japan | 3004 Medicaments | EUR 14.5 million | EUR 1.1 million 2024-12 | +EUR 13.4 million | +1,192.0% | DS-045409:NL:JP:3004:2:2025-12 DS-045409:NL:JP:3004:2:2024-12 |
| 11 | Germany imports from Netherlands | 3003 Medicaments | EUR 15.2 million | EUR 1.2 million 2024-12 | +EUR 14.0 million | +1,190.1% | DS-045409:DE:NL:3003:1:2025-12 DS-045409:DE:NL:3003:1:2024-12 |
| 12 | Netherlands exports to Chile | 3002 Human blood | EUR 17.1 million | EUR 1.6 million 2024-12 | +EUR 15.5 million | +970.1% | DS-045409:NL:CL:3002:2:2025-12 DS-045409:NL:CL:3002:2:2024-12 |
| 13 | Spain exports to Australia | 3004 Medicaments | EUR 98.7 million | EUR 9.7 million 2024-12 | +EUR 89.0 million | +914.3% | DS-045409:ES:AU:3004:2:2025-12 DS-045409:ES:AU:3004:2:2024-12 |
| 14 | Italy exports to Ireland | 3004 Medicaments | EUR 223.1 million | EUR 22.2 million 2024-12 | +EUR 200.8 million | +902.9% | DS-045409:IT:IE:3004:2:2025-12 DS-045409:IT:IE:3004:2:2024-12 |
| 15 | Italy exports to Poland | 3002 Human blood | EUR 126.4 million | EUR 12.7 million 2024-12 | +EUR 113.7 million | +897.6% | DS-045409:IT:PL:3002:2:2025-12 DS-045409:IT:PL:3002:2:2024-12 |
Data Passport
- Eurostat Comext DS-045409: monthly trade of the EU member states by partner country and product, EUR and net mass, months 2025-11, 2025-12 and 2024-12. Licence: Eurostat reuse policy, free reuse with attribution "Source: Eurostat" (© European Union). Record IDs: DS-045409:reporter:partner:product:flow:month. Source
- Method: For each EU reporter, HS4 product, partner country and flow, the value of December 2025 is compared with the month before and with the same month a year earlier. A missing month row counts as no recorded trade. Lists rank by the absolute change in EUR or by the percent change; aggregates (world, intra and extra EU) and confidential partners are left out, as are Peru and the Philippines.
Trade database built 2026-10-24. Values are official statistics as published; nothing on this page is estimated or invented. More in our methodology.
See the companies
Members see the importers and exporters behind these flows, with their evidence and Data Passport.